Ex-Novartis CEO Joe Jimenez is taking another crack at opening a new chapter in his career — and that includes a new board seat and a $250M startup
Joe Jimenez is back.
The ex-CEO of Novartis has taken a board seat on Century Therapeutics, the Versant and Bayer-backed startup focused on coming up with a brand new twist on cell therapies for cancer — a field where Jimenez made his mark backing the first personalized CAR-T approved for use.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 72,900+ biopharma pros reading Endpoints daily — and it's free.